<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="39183">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02596295</url>
  </required_header>
  <id_info>
    <org_study_id>HM001</org_study_id>
    <nct_id>NCT02596295</nct_id>
  </id_info>
  <brief_title>Human Milk Sample Composition in Israeli Mothers and Correlation With Their Diet</brief_title>
  <official_title>Human Milk Sample Collection From Israeli Mothers and Its Analysis and Correlation Between Composition, Demographics and Diet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Enzymotec</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Enzymotec</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will collect human milk from 100 mother of term infants 2-3m after delivery and
      from 50 mothers of preterm infants 14 and 30 days after delivery. Sample content will be
      analysed and statistical analysis will look at correlation between demographics, dietary
      habits and milk composition.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Breast milk composition</measure>
    <time_frame>30-60 days after delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal diet survey</measure>
    <time_frame>30-60 days after delivery</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Breast Milk Collection</condition>
  <arm_group>
    <arm_group_label>Mothers for term infants</arm_group_label>
    <description>Lactating mothers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mothers for preterm infants</arm_group_label>
    <description>Lactating mothers</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Human milk
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        General healthy lactating mothers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Generally healthy mothers who give birth to a healthy term infant (37-42 weeks) Mothers
        who intend to breastfeed the infant at least 80% of the daily feeding Mothers who can
        comply with the study requirements Mothers who sign the informed consent form in writing
        and can read and write Hebrew.

        Exclusion Criteria:

          -  Participation in any other studies involving investigational or marketed products Is
             consuming alcoholic drinks and is a drug abuser. Is suffering from chronic disease
             Presence of psychosis and severe post-partum depression. Mothers who have given birth
             to twins or multiples Mothers who received chemotherapy or isotopes during pregnancy
             investigator's uncertainty about the willingness or ability of the mothers to
             understand and comply with the protocol requirements.

        Infants:

        Any congenital abnormality, chromosomal disorder or severe disease which could interfere
        with the study conduct and assessment.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yael Lifshitz, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Employee</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yael Lifshitz, PhD</last_name>
    <email>Yaell@enzymotec.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Meir Hospital</name>
      <address>
        <city>Kfar Saba</city>
        <state>State</state>
        <zip>340000</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ita Litmanovitch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <lastchanged_date>November 3, 2015</lastchanged_date>
  <firstreceived_date>November 3, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
